Gilead Exec VP-Commercial Operations Joins From Amgen
This article was originally published in The Pink Sheet Daily
Executive Summary
Kevin Young will oversee global commercial operations and strategy for Gilead’s product portfolio, including the launch of the HIV combination therapy Truvada. At Amgen, he headed the U.S. Inflammation Business Unit and oversaw the relaunch of Enbrel.